Modeling of chronic prostatitis. Abacterial prostatitis in the aspects of reproduction of experimental hypofertility (review)

Authors

  • Koreneva E. SI «V. Danilevsky Institute of Endocrine Pathology Problems of NAMS of Ukraine», Kharkiv, Ukraine
  • Philimonova N. National Pharmaceutical University, Kharkiv, Ukraine
  • Brechka N. SI «V. Danilevsky Institute of Endocrine Pathology Problems of NAMS of Ukraine», Kharkiv, Ukraine
  • Chistyakova E. SI «V. Danilevsky Institute of Endocrine Pathology Problems of NAMS of Ukraine», Kharkiv, Ukraine
  • Smolyenko N. SI «V. Danilevsky Institute of Endocrine Pathology Problems of NAMS of Ukraine», Kharkiv, Ukraine
  • Belkina I. SI «V. Danilevsky Institute of Endocrine Pathology Problems of NAMS of Ukraine», Kharkiv, Ukraine
  • Karpenko N. SI «V. Danilevsky Institute of Endocrine Pathology Problems of NAMS of Ukraine», Kharkiv, Ukraine

DOI:

https://doi.org/10.21856/j-PEP.2019.1.13

Keywords:

experimental chronic prostatitis, modeling of the abacaviral prostatitis, hypofertility

Abstract

There is a problem of modeling of prostatitis in animals despite of the progress at the creation of prostatic protectors capable of correcting hypofertility. In this regard, modeling prostate gland pathology, monitoring its development and finding out factors causing a decrease in the generative function in prostatitis are topical issues. In this review, the important role of experimental modeling of prostatitis have been shown, the etiology, pathogenesis and clinical manifestations of prostatitis, the epidemiology of reproductive impairment in conditions of abacterial inflammatory process of the prostate gland have been reviewed, and data about methods of prostatitis modelling in laboratory animals. Such modeling of chronic abacterial prostatitis in rats has been reviewed: by rectal administration of dimexide and turpentine; by cryotrauma; piercing (traumatic) prostatitis; prostatitis after hypokinetic stress; autoimmune prostatitis; acute aseptic inflammation of the prostate gland; chronic prostatitis by applying metaxylene; as well as experimental models of prostatitis associated with hormonal effects. Summarizing the literature data, the authors conclude that the experimental modeling of chronic prostatitis is an issue of importance not only for the study of the course of this common disease, but also for the development of new methods and measures for the treatment of prostatitis and reproductive health disorders that occur on the background or accompanied by inflammation.

References

World population prospects. Key findings and advanced tables, New York, 2017, available at: https://esa.un.org/unpd/wpp/Publications/Files/WPP2017_KeyFindings.pdf.

Klymenko VI, Denysenko IM. Ukrai’na Zdorov’ja nacii’ 2011; 3: 25-29.

Gorpinchenko II, Nikitin OD. Zdorov’e Muzhchiny 2010;3: 184-190.

Gorpinchenko VI, Grishhenko VI. Zdorov’e Muzhchiny 2008; 4: 91-94.

Bondarenko VA. 100 izbrannyh lekcij po jendokrinologii, Har’kov, 2009: 548-560.

Jungwirth A, Giwercman A, Tournaye H,et al. Eur Urol 2012; 62 (2): 324-332. doi: http://doi.org/10.1016/j.eururo.2012.04.048.

Gorpynchenko II, Gurzhenko JuM, Imshynec’ka LP. Zdorov’e Muzhchiny 2014; 4: 137-149.

Pavlovich OV, Revenko OB, Gapon GO. Probl Cryobiol Cryomed 2016; 26 (1): 45-52.

Aitken RJ, Baker MA, De Iuliis GN, Nixon B. Hand Exp Pharmacol 2010; 198: 99-115. doi: http://doi.org/10.1007/978-3-642-02062-9_7.

Jurewicz J, Hanke W, Radwan M, Bonde JP. Int J Occup Med Environ Hlth 2009; 22 (4): 305-329. doi: http://doi.org/10.2478/v10001-009-036-1.

Nikitin OD. Zdorov’e Muzhchiny 2010; 2: 229-232.

Minuhin AS, Bondarenko VA, Kononenko NN. Science Rise: Medical Science 2018; 2 (22): 14-18.

Nikitin OD. Zdorov’e Muzhchiny 2010; 3: 108-116.

Ivahnenko OL, Strilec’ OP, Kabachnyj GI, et al. Zaporozh Med Zhurn 2010; 12 (2): 65-69.

Luchytskyy YV, Luchytskyy VY, Tronko MD. Іnt J Endocrinol 2017; 13 (4): 281-289.

Bansal MR, Davies AG. J Reprod Fertil 1986; 78 (219): 219-224.

Born HJ, Hörster-Poschmann P, Stoll W, et al. Acta Endocrinol 1988; 117 (4): 536-544.

Bondarenko VA. Ukrai’ns’ka shkola endokrynologii’: zbirnyk lekcij, Harkiv, 2013: 20-27.

Zajchenko GV, Jakovljeva LV, Grashhenkova SA, et al. Ukr Biofarmacevtych Zhurn 2008; 1: 16-21.

Drogovoz SM, Rossihin VV, Buhtiatova TA, et al. Prostatoprotektory, Har’kov, 2005: 184 p.

Zajchenko AV, Soldatova EA, Gricenko VI. Nauchnye vedomosti BelGU. Serija: Medicina. Farmacija 2013;25 (168): 18-27.

Dygaj AM. Rukovodstvo po provedeniju doklinicheskih issledovanij lekarstvennyh sredstv, Moskva, 2012: 725-750.

Cvetkov IS, Makarova OV, Mhitarov VA. Klin Jeksperim Morfologija 2013; 1 (5): 60-65.

Karnauh JeV, Olefir AS. Eksperym Klin Medycyna 2014;1 (62): 17-26.

Markin PM. Eksperymental’ne obgruntuvannja zastosuvannja novogo pohidnogo (2-oksoindoliniliden-3)-2-oksioctovoi’ kysloty pry zahvorjuvannjah peredmihurovoi’ zalozy, Harkiv, 2013: 12 p.

Klasyfikacija prostatytu, available at: http://tonsuaci.ru/rizne/22062-jaka-klasifikacija-prostatitu-isnue.html.

Sindrom hronicheskoj tazovoj boli, available at: http://medukrok.ru/rizne/18395-sindrom-hronichnoi-tazovoiboli.html.

Rekomendacii’ z diagnostyky, likuvannja infekcij sechovogo traktu ta cholovichyh statevyh organiv: Prostatyt (za IDDK_NIH) (Urologija): Klinichnyj protokol,available at: http://medstandart.net/browse/2482.

Prostatyt u cholovikiv — symptomy i likuvannja, available at: http://medicine.co.ua/cholovich-xvoroby/104-prostatit-y-cholovikiv.html.

Hronicheskij prostatit, available at: http://www.24farm.ru/andrologiya/hronicheskij_prostatit.

Vinarov AZ. Hronicheskij prostatit, available at: https://www.slideshare.net/uroschool/ss-73600673.

Schuppe HC, Pilatz A, Hossain H, et al. Arzteblatt Int 2017; 19 (114): 339-346. doi: http://doi.org/10.3238/arztebl.2017.0339.

Condorelli RA, Russo GI, Calogero AE, et al. J Endocrinol Invest 2017; 40 (11): 1209-1218.

Monakov DM. Patospermija pri hronicheskom prostatite: vozmozhnosti ejo korrekcii, available at: http://uroweb.ru/news/patospermiya_pri_

hronicheskom_prostatite_vozmognosti_eyo_korrektsii.

Shang Y, Liu C, Cui D, et al. Sci Rep 2014; 4: 7233. doi: http://doi.org/10.1038/srep04976.

Fu W, Zhou Z, Liu S, et al. PLoS One 2014; 9 (4): e94991.

Punab M, Kullisaar T, Mändar R. PloS One 2013; 8 (12): e82776. doi: http://doi.org/10.1371/journal.pone.0082776.

Castiglione R, Salemi M, Vicari LO, Vicari E. Andrologia 2014; 46 (10): 1148-1155. doi: http://doi.org/10.1111/and.12207.

Jiang Y, Cui D, Du Y, et al. J Reprod Immunol 2016;118: 85-91. doi: http://doi.org/10.1016/j.jri.2016.09.004.

Mihajlichenko VV, Pupkova LS, Kozlov AV. Lab Delo 1989; 4: 8-11.

Goodarzi, D, Cyrus A, Baghinia MR, et al. Acta Med Indones 2013; 45 (4): 259-264.

Lombardo F, Fiducia M, Lunghi R, et al. Andrologia 2012; 44: 672-678. doi: http://doi.org/10.1111/j.1439-0272.2011.01248.x.

Seljukova NJu, Korenjeva JeM. Svit Medycyny ta Biologii’ 2017; 2 (60): 150-153.

Krupin VN, Shhebet OV. Patogeneticheskaja terapija besplodija u bol’nyh hronicheskim prostatitom, available at: http://uroweb.ru/news/485.html.

Cvetkov IS, Makarova OV, Mhitarov VA. Morfol Vedomosti 2011; 4: 56-64.

Karakovs’ka NJe, Shhokina KG, Drogovoz SM. Ukr Biofarmacevtych Zhurn 2013; 2: 41-45.

Filimonova NI, Korenjeva JeM, Bagno GV. Liky – ljudyni. Suchasni problemy farmakoterapii’ i pryznachennja likars’kyh zasobiv»: materialy II Mizhnar. nauk.-prakt. konf., Harkiv;1: 231-237.

Patent 2182370. Sposob modelirovanija hronicheskogo prostatita.

Hejfec VH, et al. Urologija 1999; 5: 48-52.

Zajchenko GV, et al. Ukr Biofarmacevtych Zhurn 2008;1: 16-21.

Gevojan, SR, Zajchenko GV, Fajzullin OV. Ukr Biofarmacevtych Zhurn 2012; 3: 15-20.

Zajchenko AV, Tackij JuA. Jeksperim i Klin Urologija 2014; 2: 28-31.

Ravshanov TB, Zajchenko GV, Mishhenko OJa, Zajchenko VS. Aktual’ni pytannja biologii’ ta medycyny: Zbirnyk naukovyh prac’, Starobil’s’k, 2017: 133-135.

Malek FE. Farmakologichne vyvchennja novogo roslynnogo preparatu — supozytorii’v flaginat ja likuvannja prostatytiv, Harkiv, 2006: 19 p.

Andrijanenkov OV. Eksperymental’ne obg’runtuvannja vykorystannja Talabanu pol’ovogo jak korektora reproduktyvnyh

funkcij, Harkiv, 2013: 200 p.

Soldatova JeO. Farmakologichne doslidzhennja prostatoprotektornoi’ dii’ supozytorii’v z fitoekstraktamy, Harkiv, 2015: 18 p.

Lugin IA, Trocenko BV. Sovremennaja medicina: aktual’nye voprosy 2014; 37.

Keetch DW, Humphrey P, Ratliff TL. J Urol 1994; 152 (1): 247-250.

Seethalakshmi L, Bala RS, et al. J Urol 1996; 156 (5): 1838-1842.

Frolova NJu, Burjakina AV, Mel’nikova TI, et al. Jekcpepim i Klin Fapmakologija 2010; 73 (6): 41-44.

Jakovljeva LV, Jegorova OO, Koshova OJu. Tavricheskij Med-Biol Vestn 2013; 16 (1): 237-241.

Gevojan SR, Zajchenko GV. Ukr Med Al’manah 2012;3: 58-62.

Harris MT. Prostate 2000; 44 (1): 19-25.

Cvetkov IS, Makarova OV, Mhitarov VA. Med Immunologija 2011; 13 (4-5): 341-342.

Gorbachev AG, Tjurin AG. Urol Vedomosti 2015; 5 (4): 20-21.

Zeng F, Chen H, Yang J, et al. PLOS One 2014; 9 (5):e96824. doi: http://doi.org/10.1371/journal.pone.0097406.

Wagenlehner FM, van Till JW, Magri V, et al. Eur Urol 2013; 63 (5): 953-959. doi: http://doi.org/10.1016/j.eururo.2012.10.042.

Vykhovanets EV, Resnick MI, MacLennan GT, Gupta S. Prostate Cancer and Prostatic Diseases 2007; 10 (1): 15-29. doi: https://doi.org/10.1038/sj.pcan.4500930.

Chen CS, et al. Prostate 2013; 73 (4): 391-397.

Downloads

Published

2021-07-06

How to Cite

Koreneva, E. ., Philimonova, N. ., Brechka, N., Chistyakova, E. ., Smolyenko, N. ., Belkina, . I. ., & Karpenko, . N. . (2021). Modeling of chronic prostatitis. Abacterial prostatitis in the aspects of reproduction of experimental hypofertility (review). Problems of Endocrine Pathology, 67(1), 104-115. https://doi.org/10.21856/j-PEP.2019.1.13